Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
PMC
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Early evaluation and value-based pricing of regenerative medicine technologies.
Regen. Med. 8, 747-758 (2013)
Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful marketing by establishing the value of a product from a healthcare system perspective. This article reports results from a research project on early health economic evaluation in collaboration with developers, clinicians and manufacturers. We present an approach to determine an early value-based price for a new treatment of cartilage defects of the knee from the area of regenerative medicine. Examples of using evaluation results for the purpose of business planning, market entry, preparing the coverage decision and managed entry are discussed.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Business planning; Commercialization; early evaluation; Innovation management; Market access; Pricing; Reimbursement; Autologous Chondrocyte Implantation ; Osteochondral Defects ; Cartilage Lesions ; Randomized-trial ; Decision-making ; Stem-cells ; Knee ; Microfracture ; Challenges ; Industry
ISSN (print) / ISBN
1746-0751
e-ISSN
1746-076X
Journal
Regenerative Medicine
Quellenangaben
Volume: 8,
Issue: 6,
Pages: 747-758
Publisher
Future Medicine
Non-patent literature
Publications
Reviewing status
Peer reviewed